| Inactivation of PI (3) K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer K Ali, DR Soond, R Pineiro, T Hagemann, W Pearce, EL Lim, H Bouabe, ... Nature 510 (7505), 407-411, 2014 | 533 | 2014 |
| GWASdb: a database for human genetic variants identified by genome-wide association studies MJ Li, P Wang, X Liu, EL Lim, Z Wang, M Yeager, MP Wong, PC Sham, ... Nucleic acids research 40 (D1), D1047-D1054, 2012 | 236 | 2012 |
| Associations between adipokines and obesity-related cancer G Paz-Filho, EL Lim, ML Wong, J Licinio Front Biosci 16 (1), 1634-1650, 2011 | 214 | 2011 |
| Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody D Ha, A Tanaka, T Kibayashi, A Tanemura, D Sugiyama, JB Wing, EL Lim, ... Proceedings of the National Academy of Sciences 116 (2), 609-618, 2019 | 172 | 2019 |
| Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy D Gyori, EL Lim, FM Grant, D Spensberger, R Roychoudhuri, ... JCI insight 3 (11), 2018 | 111 | 2018 |
| Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias AYL So, R Sookram, AA Chaudhuri, A Minisandram, D Cheng, C Xie, ... Blood, The Journal of the American Society of Hematology 124 (9), 1502-1512, 2014 | 62 | 2014 |
| Control of foreign Ag‐specific Ab responses by Treg and Tfr JB Wing, EL Lim, S Sakaguchi Immunological reviews 296 (1), 104-119, 2020 | 45 | 2020 |
| Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors EL Lim, FM Cugliandolo, DR Rosner, D Gyori, R Roychoudhuri, ... JCI insight 3 (11), 2018 | 45 | 2018 |
| Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy EL Lim, K Okkenhaug Immunology 157 (3), 210-218, 2019 | 30 | 2019 |
| Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease A Tanaka, S Maeda, T Nomura, MA Llamas-Covarrubias, S Tanaka, L Jin, ... Journal of Experimental Medicine 220 (2), e20220386, 2022 | 11 | 2022 |
| UNC93B1 variants underlie TLR7-dependent autoimmunity C Wolf, EL Lim, M Mokhtari, B Kind, A Odainic, E Lara-Villacanas, S Koss, ... Science immunology, eadi9769, 2024 | 5 | 2024 |
| Correction: Corrigendum: Inactivation of PI (3) K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer K Ali, DR Soond, R Piñeiro, T Hagemann, W Pearce, EL Lim, H Bouabe, ... Nature 535 (7613), 580-580, 2016 | 5 | 2016 |
| Disrupted degradative sorting of TLR7 is associated with human lupus H Mishra, C Schlack-Leigers, EL Lim, O Thieck, T Magg, J Raedler, ... Science Immunology, eadi9575, 2024 | 3 | 2024 |
| Systemic Lupus Erythematosus due to Gain-of-Function Mutation in UNC93B1 C Wolf, B Kind, EL Lim, G Dückers, S Koss, K Engel, E Lara-Villacanas, ... | 1 | 2022 |
| Th17 cells with a pathogenic signature in joints of ZAP-70 mutant arthritic mice harbor unique TCR repertoires that share features with WT Tregs MA Llamas-Covarrubias, A Tanaka, MJ Loza Lopez, D Diez, Z Xu, EL Lim, ... bioRxiv, 2024.03. 01.582868, 2024 | | 2024 |
| Endosome dysfunction leads to gain-of-function TLR7 and human lupus H Mishra, C Schlack-Leigers, EL Lim, O Thieck, T Magg, J Raedler, ... bioRxiv, 2023.04. 03.535356, 2023 | | 2023 |
